Biotricity Launches New Cardiac Monitoring Pilot Program

Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service company, has announced a new pilot program for cardiac monitoring in collaboration with a major hospital system serving over 800,000 individuals. This development addresses the increasing prevalence of cardiovascular disease among U.S. adults and the looming shortage of physicians.

Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity, emphasized the significance of this partnership. He noted that it advances their mission to enhance patient care through innovative remote monitoring technology. The collaboration aims to improve patient health outcomes and provide accessible healthcare solutions.

Biotricity's unique three-channel compact cardiac monitoring device offers critical insights into patient health, leading to quicker treatments and optimized outcomes. This technology significantly enhances clinic workflow efficiency and can increase healthcare professionals' revenue fivefold. Its integration is crucial as rural hospitals face financial pressures threatening their operation.

Biotricity's solutions are set to reshape the management of cardiovascular health and other chronic diseases within major hospitals. For more information, visit Biotricity's website.